EyePoint (EYPT) Total Liabilities (2011 - 2026)
EyePoint (EYPT) reported Total Liabilities of $57.7 million for Q1 2026, down 10.01% on a YoY basis from $64.2 million in Q1 2025, and little changed sequentially from $57.9 million in Q4 2025.
EyePoint (EYPT) Total Liabilities (2011 - 2026) Analysis & Trends
EyePoint (EYPT) has 16 years of Total Liabilities data on file, last reported at $57.7 million in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities fell 10.01% year-over-year to $57.7 million; the trailing twelve-month figure through Mar 2026 stood at $57.7 million (down 10.01% YoY), and the FY2025 full-year result was $57.9 million, down 29.38% from the prior year.
- Total Liabilities steadied at $57.7 million in Q1 2026, from $57.9 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $118.4 million in Q2 2023 to a low of $51.5 million in Q3 2025.
- A 5-year average of $78.7 million and a median of $82.0 million in 2024 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities jumped 44.26% in 2023 and plunged 42.53% in 2025, its largest moves.
- Tracing EYPT's Total Liabilities over 5 years: stood at $84.0 million in 2022, then climbed by 5.8% to $88.9 million in 2023, then fell by 7.76% to $82.0 million in 2024, then fell by 29.38% to $57.9 million in 2025, then dropped by 0.24% to $57.7 million in 2026.
- Business Quant data shows EYPT's Total Liabilities at $57.7 million in Q1 2026, $57.9 million in Q4 2025, and $51.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 177.22 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 7.33 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 753.82 Mn |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 | 57.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.75 Mn |
| Dec 31, 2025 | 57.88 Mn |
| Sep 30, 2025 | 51.51 Mn |
| Jun 30, 2025 | 55.14 Mn |
| Mar 31, 2025 | 64.17 Mn |
| Dec 31, 2024 | 81.96 Mn |
| Sep 30, 2024 | 82.18 Mn |
| Jun 30, 2024 | 95.94 Mn |
| Mar 31, 2024 | 79.31 Mn |
| Dec 31, 2023 | 88.86 Mn |
| Sep 30, 2023 | 101.42 Mn |
| Jun 30, 2023 | 118.39 Mn |
| Mar 31, 2023 | 76.20 Mn |
| Dec 31, 2022 | 83.99 Mn |
| Sep 30, 2022 | 84.14 Mn |
| Jun 30, 2022 | 82.07 Mn |
| Mar 31, 2022 | 77.74 Mn |
| Dec 31, 2021 | 78.99 Mn |
| Sep 30, 2021 | 75.50 Mn |
| Jun 30, 2021 | 71.96 Mn |